Published in J Chronic Dis on May 01, 1976
The Oslo Health Study: The impact of self-selection in a large, population-based survey. Int J Equity Health (2004) 2.83
Loss to follow-up in cohort studies: bias in estimates of socioeconomic inequalities. Epidemiology (2013) 2.46
Effectiveness of general practice-based health checks: a systematic review and meta-analysis. Br J Gen Pract (2014) 1.79
Factors influencing participation in health surveys. Results from prospective population study 'Men born in 1914' in Malmö, Sweden. J Epidemiol Community Health (1986) 1.58
Non-response to baseline, non-response to follow-up and mortality in the Whitehall II cohort. Int J Epidemiol (2009) 1.51
Influence of fatness, intelligence, education and sociodemographic factors on response rate in a health survey. J Epidemiol Community Health (1989) 1.44
Demographic characteristics and health behaviours of consenters to medical examination. Results from the Welsh Heart Health Survey. J Epidemiol Community Health (1992) 1.41
Non-participation and mortality in a prospective study of cardiovascular disease. J Epidemiol Community Health (1987) 1.32
Non-responders to a postal questionnaire on respiratory symptoms and diseases. Eur J Epidemiol (1999) 1.30
Characteristics of non-participants and reasons for non-participation in a population survey in Kin-Hu, Kinmen. Eur J Epidemiol (1997) 1.10
Longitudinal, population-based study of self reported alcohol habits, high levels of sickness absence, and disability pensions. J Epidemiol Community Health (1999) 1.09
A comparison of mortality rates in three prospective studies from Copenhagen with mortality rates in the central part of the city, and the entire country. Copenhagen Center for Prospective Population Studies. Eur J Epidemiol (1998) 0.93
Myocardial infarction among men below age 40. Br Heart J (1978) 0.82
Factors associated with participation in a community senior health promotion program: a pilot study. Am J Public Health (1989) 0.81
Widespread pain - do pain intensity and care-seeking influence sickness absence? - A population-based cohort study. BMC Musculoskelet Disord (2016) 0.76
Blood pressure and global risk assessment in a Swedish population. Int J Hypertens (2012) 0.75
Adult day health care evaluation study: methodology and implementation. Adult Day Health Care Evaluation Development Group. Health Serv Res (1991) 0.75
Unit Nonresponse in a Population-Based Study of Prostate Cancer. PLoS One (2016) 0.75
Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J (2003) 17.80
Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ (1996) 11.60
Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. Br Med J (Clin Res Ed) (1984) 5.79
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J (2005) 5.40
Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial. Lancet (1981) 4.75
Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med (1984) 4.51
Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol (1995) 4.50
Reduction of sudden deaths after myocardial infarction by treatment with alprenolol. Preliminary results. Lancet (1974) 4.40
The influence of body fat distribution on the incidence of diabetes mellitus. 13.5 years of follow-up of the participants in the study of men born in 1913. Diabetes (1985) 4.23
Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II) N Engl J Med (1992) 3.87
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Coronary heart-disease after treatment of hypertension. Lancet (1978) 3.78
Smoking and myocardial infarction. Lancet (1975) 3.42
Cardiac and pulmonary causes of dyspnoea--validation of a scoring test for clinical-epidemiological use: the Study of Men Born in 1913. Eur Heart J (1987) 3.15
Multivariate analysis of risk factors for coronary heart disease. Circulation (1973) 3.04
Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group. Circulation (1990) 2.89
Comparison of Escherichia coli from bacteriuric patients with those from feces of healthy schoolchildren. J Infect Dis (1977) 2.72
Bias due to non-participation and heterogenous sub-groups in population surveys. J Chronic Dis (1983) 2.62
Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trial. J Hypertens (1987) 2.59
Prevalence of primary and secondary hypertension: studies in a random population sample. Br Med J (1976) 2.57
Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S) Circulation (1998) 2.40
Cost-effectiveness of cholesterol lowering. Results from the Scandinavian Simvastatin Survival Study (4S) Eur Heart J (1996) 2.31
Prospective study of social influences on mortality. The study of men born in 1913 and 1923. Lancet (1985) 2.26
Cholesterol lowering and the use of healthcare resources. Results of the Scandinavian Simvastatin Survival Study. Circulation (1996) 2.23
Registration of myocardial infarction in the city of Göteborg, Sweden. J Chronic Dis (1975) 2.20
Body weight and weight gain during adult life in men in relation to coronary heart disease and mortality. A prospective population study. Eur Heart J (1999) 2.16
Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study. Obes Res (1999) 2.11
Analysis of risk factors for stroke in a cohort of men born in 1913. N Engl J Med (1987) 2.08
Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study. J Am Soc Nephrol (2001) 1.94
Risk factors for myocardial infarction and death due to ischemic heart disease and other causes. Am J Cardiol (1975) 1.94
A primary preventive study of Gothenburg, Sweden. Prev Med (1972) 1.92
Cessation of smoking after myocardial infarction. Effects on mortality after 10 years. Br Heart J (1983) 1.90
The multifactor primary prevention trial in Göteborg, Sweden. Eur Heart J (1986) 1.85
Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction. DIGAMI Study Group. Diabetes Insulin-Glucose in Acute Myocardial Infarction. Eur Heart J (1996) 1.83
Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease. Scandinavian Simvastatin Survival Study Group. N Engl J Med (1997) 1.79
Smoking and abdominal obesity: risk factors for venous thromboembolism among middle-aged men: "the study of men born in 1913". Arch Intern Med (1999) 1.76
Prevalence and management of hypertension in a general population sample of Swedish men. Prev Med (1973) 1.76
Physical activity protects against coronary death and deaths from all causes in middle-aged men. Evidence from a 20-year follow-up of the primary prevention study in Göteborg. Ann Epidemiol (1997) 1.75
Psychosocial factors and venous thromboembolism: a long-term follow-up study of Swedish men. J Thromb Haemost (2007) 1.74
Beta-blockers and antithrombotic treatment for secondary prevention after acute myocardial infarction. Towards an understanding of factors influencing clinical practice. The European Secondary Prevention Study Group. Eur Heart J (1998) 1.73
Prognostic value of angiographic indices of coronary artery disease from the Coronary Artery Surgery Study (CASS). J Clin Invest (1983) 1.70
Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival Study. Arch Intern Med (1996) 1.68
The reaction of salivary substances with bacteria. J Oral Pathol (1975) 1.66
Is abdominal body fat distribution a major explanation for the sex difference in the incidence of myocardial infarction? The study of men born in 1913 and the study of women, Göteborg, Sweden. Am J Epidemiol (1992) 1.66
Stressful life events, social support, and mortality in men born in 1933. BMJ (1993) 1.66
Survival in treated hypertension: follow up study after two decades. BMJ (1998) 1.64
Self-perceived psychological stress and incidence of coronary artery disease in middle-aged men. Am J Cardiol (1991) 1.63
Coronary heart disease, cancer and mortality in male middle-aged light smokers. J Intern Med (1992) 1.62
Trends in the incidence of chronic Philadelphia chromosome negative (Ph-) myeloproliferative disorders in the city of Göteborg, Sweden, during 1983-99. J Intern Med (2004) 1.62
Low-dose metoprolol CR/XL and fluvastatin slow progression of carotid intima-media thickness: Main results from the Beta-Blocker Cholesterol-Lowering Asymptomatic Plaque Study (BCAPS). Circulation (2001) 1.62
Impact of cardiovascular risk factors on coronary heart disease and mortality among middle aged diabetic men: a general population study. BMJ (1989) 1.61
Risk factors for stroke in middle-aged men in Göteborg, Sweden. Stroke (1990) 1.59
Lack of social support and incidence of coronary heart disease in middle-aged Swedish men. Psychosom Med (1993) 1.57
Cholesterol and total mortality: need for larger trials. BMJ (1992) 1.57
Peak expiratory flow and risk of cardiovascular disease and death. A 12-year follow-up of participants in the population study of women in Gothenburg, Sweden. Am J Epidemiol (1986) 1.55
Diabetes mellitus and raised serum triglyceride concentration in treated hypertension--are they of prognostic importance? Observational study. BMJ (1996) 1.54
Risk factors for type 2 (non-insulin-dependent) diabetes mellitus. Thirteen and one-half years of follow-up of the participants in a study of Swedish men born in 1913. Diabetologia (1988) 1.53
Coronary heart disease and mortality in middle aged men from different occupational classes in Sweden. BMJ (1988) 1.53
Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men. BMJ (1990) 1.50
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994. Atheroscler Suppl (2004) 1.50
The homogeneity of the faecal coliform flora of normal school-girls, characterized by serological and biochemical properties. Med Microbiol Immunol (1978) 1.49
Secular changes in cardiovascular risk factors and attack rate of myocardial infarction among men aged 50 in Gothenburg, Sweden. Accurate prediction using risk models. J Intern Med (2008) 1.49
Optimal risk factors in the population: prognosis, prevalence, and secular trends; data from Göteborg population studies. Eur Heart J (2001) 1.49
Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian Cardiac Outcomes Trial. ASCOT investigators. J Hypertens (2001) 1.49
Risk factors for heart failure in the general population: the study of men born in 1913. Eur Heart J (1989) 1.47
Quality of life of patients with chronic stable angina before and four years after coronary revascularisation compared with a normal population. Heart (2002) 1.47
Organization and efficacy of an out-patient hypertension clinic. Acta Med Scand (1978) 1.45
Use of coronary angiography and revascularization procedures following acute myocardial infarction. A European perspective. Eur Heart J (1998) 1.45
Follow-up study of patients randomized in the Scandinavian simvastatin survival study (4S) of cholesterol lowering. Am J Cardiol (2000) 1.43
Improved long-term prognosis after myocardial infarction 1984-1991. Eur Heart J (1998) 1.42
Fatalities from myocardial infarction in Nordic countries and Lithuania. The MONICA Investigators. Eur Heart J (1997) 1.42